Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling

Galectin-1 (Gal-1) is involved in several pathological activities associated with tumor progression and chemoresistance, however, the role and molecular mechanism of Gal-1 activity in hepatocellular carcinoma (HCC) epithelial–mesenchymal transition (EMT) and sorafenib resistance remain enigmatic. In...

詳細記述

保存先:
書誌詳細
出版年:Cell Death Dis
主要な著者: Zhang, P-F, Li, K-S, Shen, Y-h, Gao, P-T, Dong, Z-R, Cai, J-B, Zhang, C, Huang, X-Y, Tian, M-X, Hu, Z-Q, Gao, D-M, Fan, J, Ke, A-W, Shi, G-M
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group 2016
主題:
Original Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4855644/
https://ncbi.nlm.nih.gov/pubmed/27100895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2015.324
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料